Aptevo Therapeutics Inc. (APVO)
Nasdaq: APVO · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 2016
Who owns Aptevo Therapeutics Inc.
As filed with the SECHolders of 5% or more
4
Niowave, Inc. holds 12.2% of Common Stock, as its SCHEDULE 13G filed Jun 22, 2026 says.
Directors and officers
11
report now, of 21 people on the record since 2016. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Niowave, Inc.
SCHEDULE 13G · filed Jun 22, 2026 · Common Stock
Ayrton Capital LLC
SCHEDULE 13G · filed Aug 13, 2025 · Common stock, par value $0.001 per share
YA II PN, Ltd.
SCHEDULE 13G · filed Jul 8, 2025 · Common Stock
CVI Investments, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · 8.2% in Feb 17, 2026
Bigger Capital Fund L P
SCHEDULE 13G · filed Jun 25, 2025 · Common Stock, $0.001 par value · reported falling below 5%, from 6.2% in Apr 8, 2025
L1 Capital Global Opportunities Master Fund, Ltd.
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock · reported falling below 5%, from 9.95% in Jun 23, 2025
Hudson Bay Capital Management LP
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock, $0.001 par value · reported falling below 5%, from 4.99% in Feb 10, 2025
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 9.1% in Sep 17, 2025
Bank of America Corporation
SCHEDULE 13G/A · filed Nov 7, 2025 · Common Stock · reported falling below 5%, from 15% in Oct 6, 2025
Mitchell P. Kopin
SCHEDULE 13G · filed Jun 25, 2025 · Common stock, par value $0.001 per share · reported falling below 5%, from 0% in Apr 25, 2025
What APVO reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 26, 2026.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 30 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Grant Grady III | Board of Directors | 0 | $0 | 0 | 1 | $0 |